Drug maker's PR firm is force behind blood clot awareness campaign.

Ray Moynihan*

*Corresponding author for this work

Research output: Contribution to journalArticleProfessional

4 Citations (Scopus)


The international public relations firm Fleishman-Hillard, working with funds from the drug maker Sanofi-Aventis, is helping run a high profile campaign to raise public awareness about blood clots.

The campaign, currently running in Australia under the banner of a coalition of health professionals, has generated headlines claiming that blood clots are more deadly than AIDS and articles suggesting that injections for patients at risk of developing clots may become mandatory.
Original languageEnglish
Pages (from-to)1460-1461
Number of pages2
JournalBMJ (Clinical research ed.)
Issue number7659
Publication statusPublished - 28 Jun 2008


Dive into the research topics of 'Drug maker's PR firm is force behind blood clot awareness campaign.'. Together they form a unique fingerprint.

Cite this